222 related articles for article (PubMed ID: 32806966)
1. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature.
Supuran CT; Capasso C
Expert Opin Ther Pat; 2020 Dec; 30(12):963-982. PubMed ID: 32806966
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2024 Jun; 34(6):465-474. PubMed ID: 38506448
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance.
Capasso C; Supuran CT
Curr Top Med Chem; 2017; 17(11):1237-1248. PubMed ID: 28049405
[TBL] [Abstract][Full Text] [Related]
4. Bacterial, fungal and protozoan carbonic anhydrases as drug targets.
Capasso C; Supuran CT
Expert Opin Ther Targets; 2015; 19(12):1689-704. PubMed ID: 26235676
[TBL] [Abstract][Full Text] [Related]
5. Biomedical applications of prokaryotic carbonic anhydrases: an update.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2024 May; 34(5):351-363. PubMed ID: 38840307
[TBL] [Abstract][Full Text] [Related]
6. Novel carbonic anhydrase inhibitors for the treatment of
Supuran CT
Expert Opin Investig Drugs; 2024 May; 33(5):523-532. PubMed ID: 38517734
[TBL] [Abstract][Full Text] [Related]
7. Anti-infective carbonic anhydrase inhibitors: a patent and literature review.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):693-704. PubMed ID: 23488877
[TBL] [Abstract][Full Text] [Related]
8. An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors.
Capasso C; Supuran CT
Curr Med Chem; 2015; 22(18):2130-9. PubMed ID: 25312213
[TBL] [Abstract][Full Text] [Related]
9. An overview of novel antimicrobial carbonic anhydrase inhibitors.
Supuran CT
Expert Opin Ther Targets; 2023; 27(10):897-910. PubMed ID: 37747071
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: an editorial.
Supuran CT
Expert Opin Ther Pat; 2013; 23(6):677-9. PubMed ID: 23461558
[TBL] [Abstract][Full Text] [Related]
11. Antiglaucoma carbonic anhydrase inhibitors: a patent review.
Masini E; Carta F; Scozzafava A; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):705-16. PubMed ID: 23627893
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
Lomelino C; McKenna R
Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs.
Supuran CT
Curr Med Chem; 2012; 19(6):831-44. PubMed ID: 22214451
[TBL] [Abstract][Full Text] [Related]
14. Biomedical applications of prokaryotic carbonic anhydrases.
Supuran CT; Capasso C
Expert Opin Ther Pat; 2018 Oct; 28(10):745-754. PubMed ID: 29973089
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Substituted Benzene-Sulfonamides and Clinically Licensed Drugs on the Catalytic Activity of CynT2, a Carbonic Anhydrase Crucial for
Del Prete S; De Luca V; Bua S; Nocentini A; Carginale V; Supuran CT; Capasso C
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545297
[TBL] [Abstract][Full Text] [Related]
16. Sulfonamide inhibition profile of the γ-carbonic anhydrase identified in the genome of the pathogenic bacterium Burkholderia pseudomallei the etiological agent responsible of melioidosis.
Del Prete S; Vullo D; Di Fonzo P; Osman SM; AlOthman Z; Donald WA; Supuran CT; Capasso C
Bioorg Med Chem Lett; 2017 Feb; 27(3):490-495. PubMed ID: 28025002
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
Nocentini A; Supuran CT
Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
[TBL] [Abstract][Full Text] [Related]
18. Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of
Abutaleb NS; Elhassanny AEM; Nocentini A; Hewitt CS; Elkashif A; Cooper BR; Supuran CT; Seleem MN; Flaherty DP
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):51-61. PubMed ID: 34894972
[No Abstract] [Full Text] [Related]
19. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
Supuran CT
Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamates.
Giovannuzzi S; Marapaka AK; Abutaleb NS; Carta F; Liang HW; Nocentini A; Pisano L; Seleem MN; Flaherty DP; Supuran CT
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2284119. PubMed ID: 37994421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
